Security key
60770K107
- Security type / class
- Equity / COMMON STOCK
- Total 13F shares
- 278,813,548
- Total 13F value
- $7,903,142,271
- Share change
- +1,847,556
- Put/Call ratio
- 131%
- SEC-reported price per share
- $28.35
- Number of holders
- 678
- Value change
- -$59,165,632
- Number of buys
- 336
- Number of sells
- 325
- Shares outstanding
- 395,449,552
Holder snapshot
7 signals
Open additional details 1 more signal available
Security identity
Names, identifiers, and filing context for this profile.
1 source field
Report period
Q1 2025
Institutions
678
Top holders
10
MRNA full security history
Ownership snapshot
Full 13F holder table
Moderna, Inc. SEC filings
Moderna, Inc. company facts
Broader feeds
Ownership snapshot
Top reported holders of MRNA - Moderna, Inc. - COMMON STOCK (13F + 13D/G + 3/4/5)
Grouped by holder across the latest SEC ownership disclosures. Start with comparable ownership when available, then verify the linked 13F, 13D/G, or 3/4/5 evidence.
Comparable stake leader
VANGUARD GROUP INC
Disclosed value leader
VANGUARD GROUP INC
Comparable rows
15/15
Latest evidence
31 Dec 2024
13F
Lead comparable stake: 10%
Showing 1-6 of 15 holder rows.
Quick read
VANGUARD GROUP INC leads the comparable SEC ownership view at 10%.
15 of 15 rows have a safely comparable ownership percentage. Use this as a filing-backed starting point, then open the detailed table for source links, reporting role, position value, share count, and filing date.
Open SEC evidence
Opens VANGUARD GROUP INC's linked filing trail.
Comparable ownership
Top 5
VANGUARD GROUP INC
10%
BAILLIE GIFFORD & CO
9.8%
BlackRock, Inc.
6.5%
FMR LLC
4.7%
STATE STREET CORP
4.4%
Ownership % is shown only when SEC disclosures are safely comparable across share classes.
Detailed SEC evidence table Showing 1-6 of 15 holder rows
| Holder | Evidence | Ownership % | Position | 12M Net Δ | As of |
|---|---|---|---|---|---|
| VANGUARD GROUP INC |
13F
Company
|
10%
|
$1,676,661,525
40,323,750 shares
|
— | 31 Dec 2024 |
| BAILLIE GIFFORD & CO |
13F
Company
|
9.8%
|
$1,617,028,362
38,889,571 shares
|
— | 31 Dec 2024 |
| BlackRock, Inc. |
13F
Company
|
6.5%
|
$1,072,429,159
25,791,947 shares
|
— | 31 Dec 2024 |
| FMR LLC |
13F
Company
|
4.7%
|
$776,075,473
18,664,634 shares
|
— | 31 Dec 2024 |
| STATE STREET CORP |
13F
Company
|
4.4%
|
$730,669,796
17,577,236 shares
|
— | 31 Dec 2024 |
| Theleme Partners LLP |
13F
Company
|
1.8%
|
$303,819,280
7,306,861 shares
|
— | 31 Dec 2024 |
How to read this table
Rows are grouped by holder and ranked first by SEC-reported ownership % when it is safely comparable, then by disclosed holdings value. — indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.
13F holder rows
Institutional holders as of Q1 2025
Investor-level positions for this CUSIP, loaded as an interactive table.
Institutions
678
Shares
278,813,548
Rows available
678
| Investor | Option | Weight % | Change % | SEC-reported value | * Price | Shares | Share Change | Activity | Report Period |
|---|
* SEC-reported price is the security price as of the portfolio date and can indicate the last known price at which the security was still held. The marker flags a reported price that did not pass the local price check.
Compare Q1 2025 vs Q1 2025 Across Filers
Q1 2025 holders
678
Q1 2025 holders
678
Holder diff
0
| Investor | Q1 2025 Shares | Q1 2025 Shares | Share Diff | Share Chg % | Q1 2025 value | Q1 2025 value | Value change | Value Chg % |
|---|